Back
Protara Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
TARA
Protara Therapeutics
Last Price:
$5.37
Seasonality Move:
26.72%
7 Day Trial
ALL ACCESS PASS
$
7
How to Turn the AI Energy Crisis into BIG Profits
And investors who move now into one technology could make a whole lot of money.-
The current trend is moderately bullish and TARA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Protara Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.67 | Sell |
| 20-day SMA: | 4.65 | Buy |
| 50-day SMA: | 3.21 | Buy |
| 200-day SMA: | 2.75 | Buy |
| 8-day EMA: | 5.42 | Sell |
| 20-day EMA: | 4.8 | Buy |
| 50-day EMA: | 3.69 | Buy |
| 200-day EMA: | 2.78 | Buy |
Protara Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.76 | Buy |
| Relative Strength Index (14 RSI): | 62.47 | Buy |
| Chaikin Money Flow: | 796791 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.54 - 5.84) | Buy |
| Bollinger Bands (100): | (1.3 - 3.84) | Buy |
Protara Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protara Therapeutics Stock
Is Protara Therapeutics Stock a Buy?
-
Protara Therapeutics share price is 5.37 while TARA 8-day simple moving average is 5.67, which is a Sell signal.
-
The stock price of TARA is 5.37 while Protara Therapeutics 20-day SMA is 4.65, which makes it a Buy.
-
Protara Therapeutics 50-day simple moving average is 3.21 while TARA share price is 5.37, making it a Buy technically.
-
TARA stock price is 5.37 and Protara Therapeutics 200-day simple moving average is 2.75, creating a Buy signal.
TARA Technical Analysis vs Fundamental Analysis
Buy
55
Protara Therapeutics (TARA)
is a Buy
Is Protara Therapeutics a Buy or a Sell?
-
Protara Therapeutics stock is rated a BuyThe current Protara Therapeutics [TARA] share price is $5.37. The Score for TARA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Protara Therapeutics Stock Info
Market Cap:
110.8M
Price in USD:
5.37
Share Volume:
996K
Protara Therapeutics 52-Week Range
52-Week High:
10.48
52-Week Low:
1.60
Buy
55
Protara Therapeutics (TARA)
is a Buy
Protara Therapeutics Share Price Forecast
-
What is the Protara Therapeutics stock price today?The Protara Therapeutics stock price is 5.37 USD today.
-
Will TARA stock go up or go down?Protara Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Protara Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protara Therapeutics is not overvalued.
Is Protara Therapeutics Stock a Buy?
-
Protara Therapeutics share price is 5.37 while TARA 8-day exponential moving average is 5.42, which is a Sell signal.
-
The stock price of TARA is 5.37 while Protara Therapeutics 20-day EMA is 4.80, which makes it a Buy.
-
Protara Therapeutics 50-day exponential moving average is 3.69 while TARA share price is 5.37, making it a Buy technically.
-
TARA stock price is 5.37 and Protara Therapeutics 200-day simple moving average is 2.78, creating a Buy signal.
Fundamental Analysis of Protara Therapeutics
Is Protara Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Protara Therapeutics
Should I short Protara Therapeutics stock?
-
TARA Moving Average Covergence Divergence (MACD) indicator is 0.76, suggesting Protara Therapeutics is a Buy
-
Protara Therapeutics Relative Strength Index (RSI) is 62.47, which suggest Protara Therapeutics is overbought
-
The Bollinger Bands (25) for Protara Therapeutics is (2.54 - 5.84), which suggest Protara Therapeutics is a Buy
-
The Bollinger Bands (100) for Protara Therapeutics is (1.3 - 3.84), which suggest Protara Therapeutics is a Buy
* Protara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.